C 24 H 24 N 4 O 3 S, monoclinic, P2 1 /c (no. 14), a = 8.772(2) Å, b = 18.777(4) Å, c = 13.697(3) Å, b = 97.52(3)°, V = 2236.7 Å 3 , Z = 4, R gt (F) = 0.0395, wR ref (F 2 ) = 0.1032, T = 113 K. (10 mmol), 4-(2-chloroethyl)morpholine hydrochloride (10 mmol), potassium carbonate (50mmol), KI (1 mmol) and acetone (25 ml) was heated under refluxed for 24h. The solvent was evaporated, a residual solid was recrystallized from EtOH. cm -1 ; 1 H-NMR (300 MHz, DMSO-d 6 ): d 7.50 (1H, t), 7.42 (2H, d), 7.22 (5H, m), 7.13 (1H, d), 7.05 (1H, t), 4.00 (2H, t), 3.89 (2H, s), 3.40 (4H, t), 2.36 (2H, t), 2.18 (4H, t); 13 C-NMR (600 MHz, DMSO-d 6 ): d 164.
Discussion
The title compound was synthesized to be used as an acetylcholinesterase inhibitor. This class of compounds display high activities against acetylcholinesterase in vitro [1] [2] [3] . The values of the geometric parameters of the title structure are within normal ranges and experimental errors. In the crystal structure, weak intermolecular C-H···O and C-H···N interactions link the molecules, in which they may be effective in the stabilization of the structure. There is also a short intramolecular contact between one of the N atoms of the thiazolo[3,2-b]-1,2,4-triazin ring (N3) and the atom O2 bridging the benzene and morpholino moiety. 4e -0.3133(2) 0.55411(7) 0.2862(1) 0.0172(7) 0.0225(7) 0.0324(7) -0.0032(6) 0.0004(6) -0.0030(6) C(8) 4e -0.1781(2) 0.56852(7) 0.36304(9) 0.0177(6) 0.0162(6) 0.0252(7) -0.0010(5) 0.0031(5) 0.0022(5) C(9) 4e -0.2038(2) 0.60437(7) 0.4565(1) 0.0188(7) 0.0184(6) 0.0263(7) -0.0001(5) 0.0056(5) 0.0019(5) C(10) 4e 0.0562(2) 0.59919(7) 0.49887(9) 0.0183(6) 0.0190(6) 0.0194(6) -0.0014(5) 0.0037(5) 0.0010(5) C(11) 4e 0.3255(2) 0.57172(7) 0.47965(9) 0.0171(6) 0.0246(7) 0.0244(7) 0.0008(5) 0.0037(5) 0.0005 (5) 
